| Literature DB >> 34417225 |
Yingcheng Wu1, Shuaixi Yang1, Jiaqiang Ma1,2, Zechuan Chen2, Guohe Song1, Dongning Rao1, Yifei Cheng1, Siyuan Huang3, Yifei Liu4, Shan Jiang2, Jinxia Liu4, Xiaowu Huang1, Xiaoying Wang1, Shuangjian Qiu1, Jianmin Xu5, Ruibin Xi3, Fan Bai6, Jian Zhou1, Jia Fan1, Xiaoming Zhang7, Qiang Gao8,9,10.
Abstract
Liver metastasis, the leading cause of colorectal cancer mortality, exhibits a highly heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 matched samples by using single-cell RNA sequencing and spatial transcriptomics. Strikingly, the metastatic microenvironment underwent remarkable spatial reprogramming of immunosuppressive cells such as MRC1 + CCL18 + M2-like macrophages. We further developed scMetabolism, a computational pipeline for quantifying single-cell metabolism, and observed that those macrophages harbored enhanced metabolic activity. Interestingly, neoadjuvant chemotherapy could block this status and restore the antitumor immune balance in responsive patients, whereas the nonresponsive patients deteriorated into a more suppressive one. Our work described the immune evolution of metastasis and uncovered the black box of how tumors respond to neoadjuvant chemotherapy. SIGNIFICANCE: We present a single-cell and spatial atlas of colorectal liver metastasis and found the highly metabolically activated MRC1 + CCL18 + M2-like macrophages in metastatic sites. Efficient neoadjuvant chemotherapy can slow down such metabolic activation, raising the possibility to target metabolism pathways in metastasis.This article is highlighted in the In This Issue feature, p. 1. ©2021 American Association for Cancer Research.Entities:
Mesh:
Year: 2021 PMID: 34417225 DOI: 10.1158/2159-8290.CD-21-0316
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397